1McCully KS. Vascular pathology of homocysteinemia:implications for the psthogenesis of arteriosclerosis [ J]. Am J pathology,1969,56:111-128.
2van Bockxmeer FM ,Mamotte CD,Vasikaran SD,et al. Methylenetetrahydrofolate reductnse sene and coronary artery disease[J]. Circulation ,1997,95 ;21-23.
3Jourdheuil-Rahmani D, Rolland PH, Roeset E, et al. Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors[J]. Cardiovasc Res,1997,34:597-602.
4Malinow MR,Bostom AG ,Krauss RM. Homocyst(e)ine,diet,and cardiovascular diseaus:A statement for healthcare professionals from the Nutrition Committee, American Heart Association [J ]. Circulation, 1999,99 : 178-182.
5Jacobsen DW, Gatautie V J, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma:sex differences and correlation with cobalamin and folate concentrations in healthy subjects [ J ]. Clin chem ,1994,40:873-881.
6Ueland PM, Refsum H. Plasma homoeysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy [ J ]. J Lab Clin Med, 1989,114:473 -501.
7Heijer M ,Blom HJ,Gorrits WBJ,et al. Is hyperhomocysteinmia a risk factor for recurrent venous thrombosis [ J ]. Lancet, 1995,354:882-889.
8Motulsky AG. Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects,and folle acid[ J]. Am J Hum Genet,1996,58:17-21.
9Schmitz C, Lindpaintre K, Verhoef P, et al. Genetic polymorphism of methylenetetrshydrofolate reductase and myocardial infarction: A case-contzol study[J]. Circulation, 1996,94 : 1812-1817.
10Gupta A, Moustnpha A, Jacobsen DW, et al. High bomocysteine, low folte and low vitamin B6 concentrations, prevalant risk factors for vascular disease in heart transplant recipients[J]. Transplantation. 1998.65 : 544-550.
